For the obesity seen in ALMS and BBS, the MC4R agonist setmelanotide [48] and GLP-1 receptor agonists (GLP-1 RAs) [49] are promising therapeutic options. The gene discussed is GLP1R; the disease is obesity due to melanocortin 4 receptor deficiency.